Post-close · Specialty Chemicals

Platform & Add-On Integration Counsel for Specialty Chemicals Acquisitions

When the deal is specialty chemicals and the question is Platform & Add-On Integration, the structure decisions in the first 30 days outlast the next five years. This is where Jason Powell works.

EV range $15M to $200M EV EBITDA $3M to $28M Audience Independent Sponsor
The deal context

An independent sponsor closing specialty chemicals transactions in the $15M to $200M EV range has a defined set of moves at the Platform & Add-On Integration stage. Most of them are not in a generic M&A textbook.

The typical specialty chemicals platform sits at $15M to $200M EV with EBITDA in the $3M to $28M range. The thesis runs on niche formulator or contract manufacturing buy-up. The IP lives in the formulator's head as often as in the company. Structure for that risk explicitly.

The moves

How Platform & Add-On Integration actually gets structured.

  1. Plan integration sequencing in the 100-day plan, with clear go-live dates.

  2. Map customer contracts, vendor relationships, and employee benefits for transfer.

  3. Update the platform's operating agreement to reflect new add-on equity and governance.

  4. Coordinate insurance program consolidation across platform and add-on entities.

  5. In specialty chemicals, layer in chemical inventory transfer filed as part of the Platform & Add-On Integration workstream.

The common mistake

Leaving the add-on as a parallel entity. The synergies live in the integration, not the addition.

Jason's take
"Integration is when the multiple actually expands. Plan it as a deal, not an aftermath."
Jason Powell · Platform & Add-On Integration
Capital after close

The deal is one thing. The capital that opens up after close is another.

Capital after close is where the IRR actually gets made. The right introductions at month nine through month thirty are where this practice works as hard as it does at the LOI.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
TALK TO JASON

An LOI on the desk, a specialty chemicals target, and a Platform & Add-On Integration question worth a real conversation.

Twenty minutes of practitioner-grade input from a securities attorney whose first move is to read the deal, not the engagement letter.